DAPASUG-VD-100

Description:

• DAPASUG-VD-100 is a bilayered sustained-release tablet combining dapagliflozin 10 mg and vildagliptin 100 mg. This formulation is intended for adults with type 2 diabetes mellitus to improve glycemic control through the synergistic action of an SGLT2 inhibitor and a DPP-4 inhibitor.
• As a trusted vildagliptin tablet manufacturer, we ensure top-quality production with strict standards. Our network also includes reliable vildagliptin tablet suppliers and dealers, catering to bulk buyers and retail markets alike. For patients and healthcare providers looking to buy vildagliptin tablets 100mg online, our distribution channels guarantee authenticity and fast delivery.

Key Features:

• Dapagliflozin facilitates glucose excretion via the kidneys, aiding in blood sugar reduction and weight management.
• Vildagliptin enhances the incretin system, promoting insulin secretion and suppressing glucagon release.
• The sustained-release design ensures a steady release of active ingredients, maintaining consistent therapeutic levels.
• Once-daily dosing regimen enhances patient compliance and simplifies treatment protocols.
• Demonstrates a low risk of hypoglycemia when used as monotherapy or in combination with other agents

Usage Guidelines:

• Take one tablet orally once daily, with or without food, as prescribed by a healthcare provider.
• Appropriate for adults with type 2 diabetes mellitus requiring dual therapy for optimal glycemic control.
• Periodic assessment of renal function is advised to ensure the safe use of dapagliflozin.

Safety Profile:

• Potential side effects include upper respiratory tract infections, headache, and gastrointestinal disturbances.
• Not indicated for patients with type 1 diabetes or diabetic ketoacidosis.
• Use with caution in individuals with renal or hepatic impairment.

Uses / Indications: TYPE 2 DIABETES